- 专利标题： HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS
-
申请号： US17183253申请日： 2021-02-23
-
公开(公告)号： US20220251087A1公开(公告)日： 2022-08-11
- 发明人: Andrew W. Buesking , Richard B. Sparks , Andrew P. Combs , Brent Douty , Nikoo Falahatpisheh , Lixin Shao , Stacey Shepard , Eddy W. Yue , Artem Shvartsbart , David M. Burns , Daniel Levy
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D471/04 ; C07D519/00
摘要：
This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
公开/授权文献
信息查询
